Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017 (2017), Article ID 3680305, 10 pages
https://doi.org/10.1155/2017/3680305
Research Article

HOXB9 Expression Correlates with Histological Grade and Prognosis in LSCC

1Department of Otorhinolaryngology, Head and Neck Surgery, The Second Affiliated Hospital, Harbin Medical University, Harbin 150086, China
2Department of Pathology, Harbin Medical University, Harbin 150081, China
3Department of Otorhinolaryngology, Head and Neck Surgery, The Fifth Affiliated Hospital, Harbin Medical University, Daqing 163316, China

Correspondence should be addressed to Yanan Sun; moc.361@2002nusnanay and Lingmei Qu; moc.621@uqiemgnil

Received 6 April 2017; Accepted 22 June 2017; Published 20 July 2017

Academic Editor: Klaus Wimmers

Copyright © 2017 Chuanhui Sun et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. A. Chu and Y. J. Kim, “Laryngeal cancer: diagnosis and preoperative work-up,” Otolaryngologic Clinics of North America, vol. 41, no. 4, pp. 673–695, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Hardisson, “Molecular pathogenesis of head and neck squamous cell carcinoma,” European Archives of Oto-Rhino-Laryngology, vol. 260, no. 9, pp. 502–508, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Y. Zhang, Z. M. Lu, X. N. Luo, L. S. Chen, and P. J. Ge, “Retrospective analysis of prognostic factors in 205 patients with laryngeal squamous cell carcinoma who underwent surgical treatment,” PLoS ONE, vol. 8, no. 4, pp. 95–98, 2013. View at Publisher · View at Google Scholar
  4. D. G. Grier, A. Thompson, A. Kwasniewska, G. J. McGonigle, H. L. Halliday, and T. R. Lappin, “The pathophysiology of HOX genes and their role in cancer,” Journal of Pathology, vol. 205, no. 2, pp. 154–171, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. B. A. Barber and M. Rastegar, “Epigenetic control of Hox genes during neurogenesis, development, and disease,” Annals of Anatomy, vol. 192, no. 5, pp. 261–274, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. J. M. Bernstein, C. R. Bernstein, C. M. L. West, and J. J. Homer, “Molecular and cellular processes underlying the hallmarks of head and neck cancer,” European Archives of Oto-Rhino-Laryngology, vol. 270, no. 10, pp. 2585–2593, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Buckingham and F. Relaix, “The role of Pax genes in the development of tissues and organs: Pax3 and Pax7 regulate muscle progenitor cell functions,” Annual Review of Cell and Developmental Biology, vol. 23, pp. 645–673, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Cillo, A. Faiella, M. Cantile, and E. Boncinelli, “Homeobox genes and cancer,” Experimental Cell Research, vol. 248, no. 1, pp. 1–9, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Carrio, G. Arderiu, C. Myers, and N. J. Boudreau, “Homeobox D10 induces phenotypic reversion of breast tumor cells in a three-dimensional culture model,” Cancer Research, vol. 65, no. 16, pp. 7177–7185, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. M. T. Lewis, “Homeobox genes in mammary gland development and neoplasia,” Breast Cancer Research, vol. 2, no. 3, pp. 158–169, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Taketani, T. Taki, N. Shibuya, A. Kikuchi, R. Hanada, and Y. Hayashi, “Novel NUP98-HOXC11 fusion gene resulted from a chromosomal break within exon 1 of HOXC11 in acute myeloid leukemia with t(11;12)(p15;q13),” Cancer Research, vol. 62, no. 16, pp. 4571–4574, 2002. View at Google Scholar · View at Scopus
  12. S. Z. Raza-Egilmez, S. N. Jani-Sait, M. Grossi, M. J. Higgins, T. B. Shows, and P. D. Aplan, “NUP98-HOXD13 gene fusion in therapy-related acute myelogenous leukemia,” Cancer Research, vol. 58, no. 19, pp. 4269–4273, 1998. View at Google Scholar · View at Scopus
  13. L. Plowright, K. J. Harrington, H. S. Pandha, and R. Morgan, “HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer),” British Journal of Cancer, vol. 100, no. 3, pp. 470–475, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. D. X. Nguyen, A. C. Chiang, X. H.-F. Zhang et al., “WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis,” Cell, vol. 138, no. 1, pp. 51–62, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Shimoda, M. Takahashi, T. Yoshimoto, T. Kono, I. Ikai, and H. Kubo, “A homeobox protein, Prox1, is involved in the differentiation, proliferation, and prognosis in hepatocellular carcinoma,” Clinical Cancer Research, vol. 12, no. 20, pp. 6005–6011, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. K. W. Tsai, Y. L. Liao, C. W. Wu, L. Y. Hu, and S. C. Li, “Aberrant expression of miR-196a in gastric cancers and correlation with recurrence,” Genes Chromosomes & Cancer, vol. 51, no. 4, pp. 394–401, 2012. View at Publisher · View at Google Scholar
  17. P. Severino, A. M. Alvares, P. Michaluart et al., “Global gene expression profiling of oral cavity cancers suggests molecular heterogeneity within anatomic subsites,” BMC Research Notes, vol. 1, no. 1, pp. 113–116, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. B. M. Bolstad, R. A. Irizarry, M. Åstrand, and T. P. Speed, “A comparison of normalization methods for high density oligonucleotide array data based on variance and bias,” Bioinformatics, vol. 19, no. 2, pp. 185–193, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCt method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Aquino, R. Franco, R. Sabatino et al., “Deregulation of paralogous 13 HOX genes in oral squamous cell carcinoma,” American Journal of Cancer Research, vol. 5, no. 10, pp. 3042–3055, 2015. View at Google Scholar · View at Scopus
  21. S. Bhatlekar, J. Z. Fields, and B. M. Boman, “HOX genes and their role in the development of human cancers,” Journal of Molecular Medicine, vol. 92, no. 8, pp. 811–823, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Wang, S. Chen, M. Xue, J. Zhong, X. Wang, and L. Gan, “Homeobox D10 gene, a candidate tumor suppressor, is downregulated through promoter hypermethylation and associated with gastric carcinogenesis,” MolMed, vol. 9, no. 18, pp. 389–400, 2012. View at Google Scholar
  23. N. Shah and S. Sukumar, “The Hox genes and their roles in oncogenesis,” Nature Reviews Cancer, vol. 10, no. 5, pp. 361–371, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Darda, F. Hakami, R. Morgan et al., “The role of HOXB9 and miR-196a in head and neck squamous cell carcinoma,” PLOS ONE, vol. 10, no. 4, Article ID e0122285, 2015. View at Publisher · View at Google Scholar
  25. R. de Barros e Lima Bueno, A. Ramão, D. G. Pinheiro et al., “HOX genes: potential candidates for the progression of laryngeal squamous cell carcinoma,” Tumor Biology, vol. 37, no. 11, pp. 15087–15096, 2016. View at Publisher · View at Google Scholar · View at Scopus
  26. C. M. Ewing, A. M. Ray, E. M. Lange et al., “Germline mutations in HOXB13 and prostate-cancer risk,” New England Journal of Medicine, vol. 366, no. 2, pp. 141–149, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Jung, R.-S. Kim, S.-J. Lee, C. Wang, and M.-H. Jeng, “HOXB13 homeodomain protein suppresses the growth of prostate cancer cells by the negative regulation of T-Cell factor 4,” Cancer Research, vol. 64, no. 9, pp. 3046–3051, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Edwards, C. Campbell, P. Flohr et al., “Expression analysis onto microarrays of randomly selected cDNA clones highlights HOXB13 as a marker of human prostate cancer,” British Journal of Cancer, vol. 92, no. 2, pp. 376–381, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. L. G. Kömüves, X.-K. Ma, E. Stelnicki, S. Rozenfeld, Y. Oda, and C. Largman, “HOXB13 homeodomain protein is cytoplasmic throughout fetal skin development,” Developmental Dynamics, vol. 227, no. 2, pp. 192–202, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. Zhao, T. Yamashita, and M. Ishikawa, “Regulation of tumor invasion by HOXB13 gene overexpressed in human endometrial cancer,” Oncology Reports, vol. 13, no. 4, pp. 721–726, 2005. View at Google Scholar · View at Scopus
  31. X.-J. Ma, Z. Wang, P. D. Ryan et al., “A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen,” Cancer Cell, vol. 5, no. 6, pp. 607–616, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. J. F. Reid, L. Lusa, L. De Cecco et al., “Limits of predictive models using microarray data for breast cancer clinical treatment outcome,” Journal of the National Cancer Institute, vol. 97, no. 12, pp. 927–930, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Miao, Z. Wang, H. Provencher et al., “HOXB13 promotes ovarian cancer progression,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 43, pp. 17093–17098, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Okuda, M. Toyota, W. Ishida et al., “Epigenetic inactivation of the candidate tumor suppressor gene HOXB13 in human renal cell carcinoma,” Oncogene, vol. 25, no. 12, pp. 1733–1742, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. K. Maeda, J.-I. Hamada, Y. Takahashi et al., “Altered expressions of HOX genes in human cutaneous malignant melanoma,” International Journal of Cancer, vol. 114, no. 3, pp. 436–441, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Goldhirsch, W. C. Wood, A. S. Coates, R. D. Gelber, B. Thürlimann, and H.-J. Senn, “Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St Gallen international expert consensus on the primary therapy of early breast cancer 2011,” Annals of Oncology, vol. 22, no. 8, pp. 1736–1747, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. K. Makiyama, J.-I. Hamada, M. Takada et al., “Aberrant expression of HOX genes in human invasive breast carcinoma,” Oncology Reports, vol. 13, no. 4, pp. 673–679, 2005. View at Google Scholar · View at Scopus
  38. M. Cantile, R. Franco, A. Tschan et al., “HOX D13 expression across 79 tumor tissue types,” International Journal of Cancer, vol. 125, no. 7, pp. 1532–1541, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. Z. B. Zhong, M. Shan, J. Wang et al., “HOXD13 methylation status is a prognostic indicator in breast cancer,” International Journal of Clinical & Experimental Pathology, vol. 8, no. 9, pp. 10716–10724, 2015. View at Google Scholar
  40. B. Argiropoulos and R. K. Humphries, “Hox genes in hematopoiesis and leukemogenesis,” Oncogene, vol. 26, no. 47, pp. 6766–6776, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. R. Calvo, J. West, W. Franklin et al., “Altered HOX and WNT7A expression in lung cancer,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 23, pp. 12776–12781, 2000. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Nagel, C. Burek, L. Venturini et al., “Comprehensive analysis of homeobox genes in Hodgkin lymphoma cell lines identifies dysregulated expression of HOXB9 mediated via ERK5 signaling and BMI1,” Blood, vol. 109, no. 7, pp. 3015–3023, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. B. Shrestha, K. I. Ansari, A. Bhan, S. Kasiri, I. Hussain, and S. S. Mandal, “Homeodomain-containing protein HOXB9 regulates expression of growth and angiogenic factors, facilitates tumor growth in vitro and is overexpressed in breast cancer tissue,” FEBS Journal, vol. 279, no. 19, pp. 3715–3726, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. G. de Pinieux, M. E. Legrier, F. Poirson-Bichat et al., “Clinical and experimental progression of a new model of human prostate cancer and therapeutic approach,” American Journal of Pathology, vol. 159, no. 2, pp. 753–764, 2001. View at Publisher · View at Google Scholar · View at Scopus
  45. T. Hayashida, F. Takahashi, N. Chiba et al., “HOXB9, a gene overexpressed in breast cancer, promotes tumorigenicity and lung metastasis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 3, pp. 1100–1105, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. T. Yamagishi, S. Hirose, and T. Kondo, “Secondary DNA structure formation for Hoxb9 promoter and identification of its specific binding protein,” Nucleic Acids Research, vol. 36, no. 6, pp. 1965–1975, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. H. Seki, T. Hayashida, H. Jinno et al., “HOXB9 expression promoting tumor cell proliferation and angiogenesis is associated with clinical outcomes in breast cancer patients,” Annals of Surgical Oncology, vol. 19, no. 6, pp. 1831–1840, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Sha, Y. Gu, B. Xu et al., “Decreased expression of HOXB9 is related to poor overall survival in patients with gastric carcinoma,” Digestive & Liver Disease, vol. 45, no. 5, pp. 422–429, 2013. View at Publisher · View at Google Scholar
  49. R. Morgan, A. Boxall, K. J. Harrington et al., “Targeting the HOX/PBX dimer in breast cancer,” Breast Cancer Research and Treatment, vol. 136, no. 2, pp. 389–398, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. T. Ji, M. Lee, S. C. Pruitt, and D. G. Hangauer, “Privileged scaffolds for blocking protein-protein interactions: 1,4-Disubstituted naphthalene antagonists of transcription factor complex HOX-PBX/DNA,” Bioorganic and Medicinal Chemistry Letters, vol. 14, no. 15, pp. 3875–3879, 2004. View at Publisher · View at Google Scholar · View at Scopus